================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
====================
Schedule 14D-9
SOLICITATION/RECOMMENDATION STATEMENT UNDER
SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
====================
CONVERIUM HOLDING AG
(Name of Subject Company)
CONVERIUM HOLDING AG
(Name of Person Filing Statement)
Registered Shares, Nominal Value CHF 5 Per Share
American Depositary Shares, each representing one half of one Registered Share
(Title of Class of Securities)
Registered Shares*
American Depositary Shares (CUSIP: 21248N107)
(CUSIP Number of Class of Securities)
====================
Christian Felderer
Converium Holding AG
Dammstrasse 19
CH-6301 Zug
Switzerland
+41 44 639 9335
(Name, Address and Telephone Number of Person Authorized to Receive Notice and
Communications on Behalf of the Person Filing Statement)
====================
With copies to:
Gregory B. Astrachan, Esq.
Willkie Farr & Gallagher LLP
1 Angel Court
London EC2R 7HJ
England
+44 207 696 5454
*There is no CUSIP Number assigned to the Registered Shares.
[X] Check the box if the filing relates solely to preliminary communications
made before the commencement of a tender offer.
================================================================================
News release
Converium Holding Ltd, Zug
Zug, Switzerland - April 5, 2007 - Converium response to SCOR offer to be
expected within the legally required period
Converium, a leading international professional reinsurer, issued the following
statement today in response to the announcement by its competitor, SCOR S.A.,
that SCOR commenced a tender offer for outstanding registered shares of
Converium.
The Board of Directors will make its recommendation regarding the offer and
state its reasons for such position within the time legally required after the
commencement of the tender offer. Accordingly, the Converium Board of Directors
urges its shareholders to defer making a determination with regard to the tender
offer until they have been advised of the Board of Directors' position.
Converium shareholders are strongly advised to carefully read Converium's
solicitation/recommendation statement when it becomes available regarding the
tender offer by SCOR because it will contain important information which should
be considered before any decision is made with respect to the tender offer.
Copies of the solicitation/recommendation statement will be filed by Converium
with the Securities and Exchange Commission and will be available at the SEC's
web site at www.sec.gov, or at the Converium website at www.converium.com.
Enquiries
Beat W. Werder Marco Circelli
Head of Public Relations Head of Investor Relations
beat.werder@converium.com marco.circelli@converium.com
Phone: +41 44 639 90 22 Phone: +41 44 639 91 31
Fax: +41 44 639 70 22 Fax: +41 44 639 71 31
Dr. Kai-Uwe Schanz Inken Ehrich
Chief Communication & Corporate Investor Relations Specialist
Development Officer inken.ehrich@converium.com
kai-uwe.schanz@converium.com Phone: +41 44 639 90 94
Phone: +41 44 639 90 35 Fax: +41 44 639 70 94
Fax: +41 44 639 70 35
About Converium
Converium is an independent international multi-line reinsurer known for its
innovation, professionalism and service. Today Converium employs about 500
people in 15 offices around the globe and is organized into three business
segments: Standard Property & Casualty Reinsurance, Specialty Lines and Life &
Health Reinsurance. Converium has an "A-" ("strong") financial strength rating
(outlook stable) from Standard & Poor's and a "B++" financial strength rating
(outlook positive) from A.M. Best Company.
1
Important Disclaimers
This document contains forward-looking statements as defined in the U.S. Private
Securities Litigation Reform Act of 1995. It contains forward-looking statements
and information relating to the Company's financial condition, results of
operations, business, strategy and plans, based on currently available
information. These statements are often, but not always, made through the use of
words or phrases such as `seek to', `expects', `aims' `should continue',
`believes', `anticipates', `estimates' and `intends'. The specific
forward-looking statements cover, among other matters, our combined ratio,
return on equity and premium volume and expense reduction targets, our plans to
use capital more efficiently and to return capital to shareholders, the
reinsurance market, the Company's operating results, the Company's dividend
policy, the prospects for improving our results, investment yield and market
share. Such statements are inherently subject to certain risks and
uncertainties. Actual future results and trends could differ materially from
those set forth in such statements due to various factors. Such factors include
our ability to refinance our outstanding indebtedness and increase our use of
hybrid capital; uncertainties of assumptions used in our reserving process; risk
associated with implementing our business strategies and our capital improvement
measures; cyclicality of the reinsurance industry; the occurrence of natural and
man-made catastrophic events with a frequency or severity exceeding our
estimates; acts of terrorism and acts of war; changes in economic conditions,
including interest and currency rate conditions that could affect our investment
portfolio; actions of competitors, including industry consolidation and
development of competing financial products; a decrease in the level of demand
for our reinsurance or increased competition in our industries or markets; our
ability to expand into emerging markets; our ability to enter into strategic
investment partnerships; a loss of our key employees or executive officers
without suitable replacements being recruited within a suitable period of time;
our ability to address material weaknesses we have identified in our internal
control environment; political risks in the countries in which we operate or in
which we reinsure risks; the passage of additional legislation or the
promulgation of new regulation in a jurisdiction in which we or our clients
operate or where our subsidiaries are organized; the effect on us and the
insurance industry as a result of the investigations being carried out by the US
Securities and Exchange Commission, New York's Attorney General and other
governmental authorities; our ability to regain past customers following any
rating upgrades and the resolution of the investigations being carried out by
the US Securities and Exchange Commission, New York's Attorney General and other
governmental authorities; changes in our investment results due to the changed
composition of our invested assets or changes in our investment policy; failure
of our retrocessional reinsurers to honor their obligations or changes in the
credit worthiness of our reinsurers; our failure to prevail in any current or
future arbitration or litigation; and extraordinary events affecting our
clients, such as bankruptcies and liquidations, and other risks and
uncertainties, including those detailed in the Company's filings with the U.S.
Securities and Exchange Commission (including, but not limited to, our Annual
Report on Form 20-F filed with the U.S. Securities and Exchange Commission) and
the SWX Swiss Exchange. The Company does not assume any obligation to update any
forward-looking statements, whether as a result of new information, future
events or otherwise.
2